« Previous · Tax Update Blog Home · Next »
An IRS Chief Counsel's Office memo reported today by Tax Analysts studies the $64 question:
Whether the taxpayer's costs for male-to-female gender reassignment surgery (and related medications, treatments, and transportation) paid during Year 6 may be deducted as medical expenses under I.R.C. § 213.
Conclusion? The IRS isn't going to stick its, er, neck out on this one:
Without an unequivocal expression of Congressional intent that expenses of this type qualify under section 213, allowing the medical expense deduction is not justified in this case.
Showing once again that a deduction isn't always deductible.
Bookmark: del.icio.us • Digg • reddit
The items included in the Tax Update Blog are informational only and are not meant as tax advice. Consult with your tax advisor to determine how any item applies to your situation.
Joe Kristan writes the Tax Update items, and any opinions expressed or implied are not neccesarily shared by anyone else at Roth & Company, P.C. Address questions or comments on Tax Updates to